Search Results - Viktoria Georgiyevna Barskova
-
1
Nimesulid. Illyuzii, allyuzii, real'nost' v mire dokazatel'noy i prakticheskoy meditsiny
Published 2010-09-01 Get full text
Article -
2
Bolezn' Lesha-Nikhena: klinicheskie proyavleniya i varianty techeniya, analiz sobstvennogo opyta
Published 2010-09-01 Get full text
Article -
3
V pomoshch' molodomu revmatologu: na prieme bol'noy s podagricheskim artritom
Published 2010-09-01 Get full text
Article -
4
Use of etoricoxib in patients with gout in real clinical practice
Published 2013-06-01Get full textObjective: to evaluate the efficacy and safety of etoricoxib (Arcoxia ®) in gouty patients with an acute arthritis attack in real clinical practice. Subjects and methods. Thirty patients (25 men and 5 women; mean age 52.4±13.5 years) with crystal-verified gout participated in the pi...
Article -
5
COLCHICINE IN RHEUMATOLOGY: YESTERDAY AND TODAY. WILL THERE BE TOMORROW?
Published 2010-06-01Get full textThe paper gives data on the efficacy and safety of colchicine in a number of rheumatic diseases (gout, Behcet's disease) and Mediterranean fever. It also discusses its toxicity
Article -
6
What does a study of nonsteroidal anti-inflammatory drug sales statistics give the Russian Federation?
Published 2011-09-01Get full textThe paper analyzes the data obtained by Pharmexpert on the sales of nonsteroidal anti-inflammatory drugs in the Russian Federation. Ibuprofen, ketorolac, diclofenac, and nimesulide are sales leaders. Possible reasons for the popularity of a number of medications and whether it is expedient to use in...
Article -
7
Cardiovascular safety of etoricoxib
Published 2011-09-01Get full textMeticulous attention is paid to the cardiovascular safety of nonsteroidal anti-inflammatory drugs (NSAIDs), the so-called selective cyclooxy-genase 2 (COX-2) inhibitors in particular. The author considers precisely this matter in case of Russia's recent NSAID etoricoxib that has been tested alo...
Article -
8
VALUE OF THE PHYTODRUGS PROLIT AND URISAN IN THE TREATMENT OF GOUTY PATIENTS
Published 2010-09-01Get full textObjective: to study the safety and efficacy of Urisan and Prolit in patients with gout. Subjects and methods. The study enrolled 45 patients who met the Wallace classification criteria for gout, were in the attack-free interval and received no antihyperuricemic therapy. The patients' mean age w...
Article -
9
European League Against Rheumatism recommendations for terminology and diagnosis of calcium pyrophosphate crystal deposition disease: An expert's comments
Published 2011-09-01Get full textV etoy stat'e my provodim obsuzhdenie 9 rekomendatsiy, kotorye razrabotany standartnym metodom sochetaniya dokazatel'nykh issledovaniy i konsensusa ekspertov. V svyazi s bol'shim spektrom klinicheskikh fenotipov deponirovaniya kristallov pirofosfata kal'tsiya (PFK) terapiya bolez...
Article -
10
Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis
Published 2012-03-01Get full textThe impact of a 4-week course of therapy with Uralyt-U (potassium-sodium hydrocitrate) on uric acid (UA) metabolic parameters was studied in patients with gout and nephrolithiasis. Elevated daily urinary excretion of UA was found to be directly correlated with its lower serum level after 4-week ther...
Article -
11
Experience in treating a gout patient with adrenal insufficiency
Published 2012-12-01 Get full text
Article -
12
Arterial hypertension in gout patients: Pathogenesis bases, clinical value, diagnosis
Published 2012-12-01Get full textCardiovascular diseases (CVD) caused by vascular atherosclerotic lesion are the leading cause of death in gout patients. Analysis of the data available in the literature has indicated that monitoring blood pressure and target organ damage thoroughly serves as the basis for the prevention of CVD and...
Article -
13
Rheumatic manifestations of endocrine diseases: skeletal diseases in hypoparathyroidism
Published 2013-10-01Get full textParathyroid diseases cause serious musculoskeletal problems. The major function of parathyroid hormone (PTH) is to regulate calcium levels in the body, which is closely related to vitamin D. PTH exerts a double (anabolic and catabolic) effect on the human skeleton, which accounts for its heterogeneo...
Article -
14
PYROPHOSPHATE ARTHROPATHY IS A RHEUMATOLOGICAL ICEBERG SYNDROME: TIME TO REASSESS ITS IMPORTANCE IN JOINT DISEASES
Published 2010-06-01Get full textThe paper provides the present views of the epidemiology, pathogenesis, diagnosis, and classification of pyrophosphate arthropathy (PPA). It describes a morphological study of the structure of the knee joint after total prosthetics in a patient diagnosed as having osteoarthrosis. Reasons for low det...
Article